Paperpal Prime Logo

Assay and Drug Development Technologies : Impact Factor & More

eISSN: 1557-8127pISSN: 1540-658X

Key Metrics

CiteScore
2.7
H-Index
62
Impact Factor
< 5
SJR
Q3Drug Discovery
SNIP
0.56
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Assay and Drug Development Technologies

Assay and Drug Development Technologies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Assay and Drug Development Technologies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Assay and Drug Development Technologies

Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
  • 23 Jul 2026
  • Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
  • 1 Jul 2026
  • Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
  • 25 Jun 2026
  • Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
  • 23 Jun 2026
  • Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
  • 16 Jun 2026
  • Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
  • 18 Apr 2026
  • Assay and drug development technologies
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
  • 23 Jul 2026
  • Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
  • 1 Jul 2026
  • Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
  • 25 Jun 2026
  • Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
  • 23 Jun 2026
  • Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
  • 16 Jun 2026
  • Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
  • 18 Apr 2026
  • Assay and drug development technologies

FAQs on Assay and Drug Development Technologies